The Altman Clinical and Translational Research Institute (ACTRI) at University of California San Diego received a five-year, $54.7 million Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health (NIH). In a recognition of research excellence and performance, this grant is actually the third major award since UCSD’s ACTRI launched in 2010; approximately $144 million has been raised by top researchers at the University of California research center. With impressive leadership, the group embarks on the next stage of scaling out a dynamic, progressive, and innovative research operation.
Research “Intrapreneurs” in San Diego Life Sciences Hub
Back in 2010, CTSA secured its first grant, which essentially helped to get the research center off the ground, up and running, reported Gary S. Firestein, MD, founding director and dean and associate vice chancellor of clinical and translational research at UC San Diego School of Medicine. Many institutions struggle after that point, not necessarily easily making the transition from research “startup” operation to an operational center co...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).